Pfizer Inc.
Albert Bourla (Chairman & CEO) reports PFE insider transactions
AI-generated summary
Albert Bourla, Chairman & CEO, Director of Pfizer Inc., acquired 20 shares of Phantom Stock Units SSP at $29.44 per share on October 15, 2026. Following this transaction, the insider directly held 783,997 shares. The transaction was a grant under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
Key facts
- Insider
- Albert Bourla · Chairman & CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | A · grantPhantom Stock Units SSPFootnotes F1, F2 | +20 | $29.44 | $588.80 | 783,997 | Direct |
Footnotes
- F1 Each unit represents one phantom share of common stock.
- F2 These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
More PFE filings
- 4
Filed Nov 3, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 3, 2026
- SC 13G
Filed Oct 16, 2026
- 4
Filed Oct 14, 2026
- 4
Filed Oct 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.